During the past decade, Wilgers Oncology Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilgers Oncology Centre" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Amgen" with 1 trials sponsored, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored and "Arcus Biosciences, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilgers Oncology Centre" #1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "PharmaEngine" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Wilgers Oncology Centre" are "Triple-Negative Breast Cancer" (2 trials), "Adult Soft Tissue Sarcoma" (1 trials), "Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial" (1 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Wilgers Oncology Centre" in a lesser frequency.

Most popular intervention types in "Wilgers Oncology Centre" are "Drug" (11 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Cisplatin" (3 trials), "Paclitaxel" (3 trials), "Carboplatin" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wilgers Oncology Centre" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wilgers Oncology Centre". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wilgers Oncology Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wilgers Oncology Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Wilgers Oncology Centre has several departments that took part in Clinical trials: "Albert Alberts Stem Cell Transplant Centre" - 4 trials